U.S. Markets close in 2 hrs, 12 mins
| Symbol | Value | Change | Percentage Change |
|---|---|---|---|
| DJIA | 9,025.29 | 574.10 | 6.79% |
| NASDAQ | 1,770.27 | 120.76 | 7.32% |
| S&P 500 | 961.97 | 62.75 | 6.98% |
| Day Low 09:51 AM EDT | 3.00 | |
|---|---|---|
| Day High 10:39 AM EDT | 4.00 |
|
| Range | 1.00 | |
| Volume | 19,510 | |
| 30-Day Avg. Vol. | 16,000 |
|
| Difference | 21.94% | |
| Market Cap. | 69.67 M | |
| Change | 7.78 M | |
| Shares Out. | 17.68 M | |
| Percent Traded | 0.11% | |
| Revenue (LFY) | — | |
| Earnings (TTM) | — | |
| Next Earnings | 12/15/2008 |
|
| EPS (TTM) | 1.96 |
| 52-Wk Low 10/10/08 | 2.99 | |
|---|---|---|
| 52-Wk High 1/7/08 | 9.74 |
|
| Range | 6.75 | |
| Prev. Close 10/10/08 | 3.50 | |
| Today's Open | 3.29 | |
| Change | -6.00% | |
| Dividend (TTM) | — | |
| Div. Yield (TTM) | — |
|
| Beta | — | |
| P/E Ratio (TTM) | 2.01 | |
| P/E Ratio (Fwd.) | -2.00 |
Retro is big these days, including in the drugmaking world. ARYx Therapeutics is developing drugs using its "RetroMetabolic Drug Design" technology, which takes old drugs and makes them better and safer. ... View Full Description
| Earnings/Share(EPS) | Estimate | Actual | Difference |
|---|---|---|---|
| 2 Quarters Ago | -0.343 3/31/08 | -0.54 3/31/08 |
-0.197
Missed
|
| Last Quarter | -0.635 6/30/08 | -0.67 6/30/08 |
-0.035
Missed
|
| Quarterly - | Annual - | |
|---|---|---|
| Total Revenue | — | — |
| Gross Profit | — | — |
| Operating Income | — | — |
| Net Income | — | — |
